Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Puf60em1flox/Cya
Common Name:
Puf60-flox
Product ID:
S-CKO-13987
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Puf60-flox
Strain ID
CKOCMP-67959-Puf60-B6J-VA
Gene Name
Puf60
Product ID
S-CKO-13987
Gene Alias
2410104I19Rik; 2810454F19Rik; SIAHBP1
Background
C57BL/6JCya
NCBI ID
67959
Modification
Conditional knockout
Chromosome
15
Phenotype
MGI:1915209
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Puf60em1flox/Cya mice (Catalog S-CKO-13987) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000100527
NCBI RefSeq
NM_028364
Target Region
Exon 6~12
Size of Effective Region
~3.0 kb
Detailed Document
Click here to download >>
Overview of Gene Research
PUF60, also known as Poly(U) binding splicing factor 60 kDa, is a nucleic acid-binding protein involved in multiple nuclear processes. It is essential for embryonic development, regulating gene expression and cellular growth through pre-mRNA splicing, apoptosis, and transcription regulation [2,4].

PUF60 depletion inhibits the G2/M transition of the cell cycle in lung adenocarcinoma cells, leading to reduced cell proliferation and tumor development. This is because PUF60 knockdown causes exon skipping in genes like CDC25C, resulting in nonsense-mediated mRNA decay and decreased protein levels [1].

In glioblastoma, PUF60 knockdown significantly decreases cell proliferation in vitro and in vivo by reducing the ubiquitination level of EGFR through transcriptional regulation of STUB1 [3].

In bladder cancer, PUF60 knockdown inhibits cell viability and colony formation, while its overexpression promotes these processes, and it activates the transcription of AURKA [5].

In breast cancer, upregulation of PUF60 accelerates cancer progression by downregulating PTEN expression [6].

In ovarian cancer, silencing PUF60 enhances the stability of mRNA transcripts involved in oxidative phosphorylation, reducing tumor cell proliferation and migration [7].

In conclusion, PUF60 is crucial for normal development and its dysregulation is involved in multiple cancers. Loss-of-function studies in various cancer cell models have revealed its role in promoting tumor progression through different molecular mechanisms, suggesting it could be a potential therapeutic target for cancer treatment.

References:
1. Xu, Nan, Ren, Yunpeng, Bao, Yufang, Xie, Gangcai, Wang, Yongbo. 2023. PUF60 promotes cell cycle and lung cancer progression by regulating alternative splicing of CDC25C. In Cell reports, 42, 113041. doi:10.1016/j.celrep.2023.113041. https://pubmed.ncbi.nlm.nih.gov/37682709/
2. Hoogenboom, Amarens, Falix, Farah A, van der Laan, Liselot, Sadikovic, Bekim, van Haelst, Mieke M. 2024. Novel PUF60 variant suggesting an interaction between Verheij and Cornelia de Lange syndrome: phenotype description and review of the literature. In European journal of human genetics : EJHG, 32, 435-439. doi:10.1038/s41431-023-01527-1. https://pubmed.ncbi.nlm.nih.gov/38273166/
3. Wang, Fang, Peng, Lan, Sun, Yikui, Zhang, Burong, Lu, Shuaijun. 2022. PUF60 promotes glioblastoma progression through regulation of EGFR stability. In Biochemical and biophysical research communications, 636, 190-196. doi:10.1016/j.bbrc.2022.10.082. https://pubmed.ncbi.nlm.nih.gov/36335869/
4. Bach, Michal Yacobi, Miron, Sivan Reytan, Kurolap, Alina, Feldman, Hagit Baris. 2024. PUF60 loss-of-function with normal cognition should be considered in the differential diagnosis of Klippel-Feil syndrome. In American journal of medical genetics. Part A, 194, e63550. doi:10.1002/ajmg.a.63550. https://pubmed.ncbi.nlm.nih.gov/38297485/
5. Long, Qian, An, Xin, Chen, Miao, Zheng, Fufu, He, Liru. 2020. PUF60/AURKA Axis Contributes to Tumor Progression and Malignant Phenotypes in Bladder Cancer. In Frontiers in oncology, 10, 568015. doi:10.3389/fonc.2020.568015. https://pubmed.ncbi.nlm.nih.gov/33117697/
6. Sun, Dongying, Lei, Wei, Hou, Xiaodong, Li, Hui, Ni, Wenlu. 2019. PUF60 accelerates the progression of breast cancer through downregulation of PTEN expression. In Cancer management and research, 11, 821-830. doi:10.2147/CMAR.S180242. https://pubmed.ncbi.nlm.nih.gov/30697074/
7. Zhang, Cancan, Ni, Xiaoge, Tao, Chunlin, Wu, Zhiyong, Zhang, Rong. 2023. Targeting PUF60 prevents tumor progression by retarding mRNA decay of oxidative phosphorylation in ovarian cancer. In Cellular oncology (Dordrecht, Netherlands), 47, 157-174. doi:10.1007/s13402-023-00859-w. https://pubmed.ncbi.nlm.nih.gov/37632669/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest